Moberg Pharma AB Statistics
Total Valuation
MBGPF has a market cap or net worth of 44.07 million. The enterprise value is 16.50 million.
| Market Cap | 44.07M |
| Enterprise Value | 16.50M |
Important Dates
The last earnings date was Tuesday, May 13, 2025.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 46.69M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +108.43% |
| Shares Change (QoQ) | +2.75% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 41.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 34.40 |
| PB Ratio | 0.65 |
| P/TBV Ratio | 0.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.66 |
| EV / Sales | 12.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.45, with a Debt / Equity ratio of 0.01.
| Current Ratio | 18.45 |
| Quick Ratio | 18.06 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,473.04 |
Financial Efficiency
Return on equity (ROE) is -38.96% and return on invested capital (ROIC) is -30.91%.
| Return on Equity (ROE) | -38.96% |
| Return on Assets (ROA) | -30.07% |
| Return on Invested Capital (ROIC) | -30.91% |
| Return on Capital Employed (ROCE) | -46.70% |
| Revenue Per Employee | 142,351 |
| Profits Per Employee | -2.78M |
| Employee Count | 10 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.72 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.02% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -64.02% |
| 50-Day Moving Average | 0.82 |
| 200-Day Moving Average | 1.63 |
| Relative Strength Index (RSI) | 60.63 |
| Average Volume (20 Days) | 10,992 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MBGPF had revenue of 1.28 million and -25.04 million in losses. Loss per share was -0.59.
| Revenue | 1.28M |
| Gross Profit | 835,640 |
| Operating Income | -31.99M |
| Pretax Income | -31.50M |
| Net Income | -25.04M |
| EBITDA | -31.93M |
| EBIT | -31.99M |
| Loss Per Share | -0.59 |
Balance Sheet
The company has 26.79 million in cash and 373,787 in debt, giving a net cash position of 26.41 million.
| Cash & Cash Equivalents | 26.79M |
| Total Debt | 373,787 |
| Net Cash | 26.41M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 68.29M |
| Book Value Per Share | 1.46 |
| Working Capital | 26.53M |
Cash Flow
| Operating Cash Flow | -2.13M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 65.23% |
| Operating Margin | -2,497.08% |
| Pretax Margin | -2,458.39% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MBGPF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -108.43% |
| Shareholder Yield | n/a |
| Earnings Yield | -56.83% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |